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ed January 21, 2013.his study sought to determine the value of 18F-ﬂuorodeoxyglucose positron emission tomography/computed
tomography (18F-FDG PET/CT) for diagnosing prosthetic valve endocarditis (PVE).Background The diagnosis of PVE remains challenging. In PVE cases, initial echocardiography is normal or inconclusive in almost
30%, leading to a decreased diagnostic accuracy for the modiﬁed Duke criteria.Methods We prospectively studied 72 consecutive patients suspected of having PVE. All of the patients were subjected to
clinical, microbiological, and echocardiographic evaluation. Cardiac PET/CT was performed at admission. The ﬁnal
diagnosis was deﬁned according to the clinical and/or pathological modiﬁed Duke criteria determined during a
3-month follow-up.Results Thirty-six patients (50%) exhibited abnormal FDG uptake around the site of the prosthetic valve. The sensitivity,
speciﬁcity, positive predictive value, negative predictive value, and global accuracy were as follows (95% conﬁdence
interval): 73% (54% to 87%), 80% (56% to 93%), 85% (64% to 95%), 67% (45% to 84%), and 76% (63% to 86%),
respectively. Adding abnormal FDG uptake around the prosthetic valve as a newmajor criterion signiﬁcantly increased
the sensitivity of the modiﬁed Duke criteria at admission (70% [52% to 83%] vs. 97% [83% to 99%], p¼ 0.008). This
result was due to a signiﬁcant reduction (p< 0.0001) in the number of possible PVE cases from 40 (56%) to 23 (32%).Conclusions The use of 18F-FDG PET/CT was helpful for diagnosing PVE. The results of this study support the addition of
abnormal FDG uptake as a novel major criterion for PVE. (J Am Coll Cardiol 2013;61:2374–82) ª 2013 by the
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Currently, the modiﬁed Duke criteria are considered to be
the gold standard for diagnosing infective endocarditis.
Based on clinical, echocardiographic, microbiological, and
pathological ﬁndings, these criteria provide a diagnostic
probability, classiﬁed as deﬁnite, possible, or rejected endo-
carditis (4). This classiﬁcation has a sensitivity of approxi-
mately 80% when the criteria are evaluated at the end of
patient follow-up in epidemiological studies (2,5). However,
in clinical practice, the modiﬁed Duke criteria show a lower
diagnostic accuracy for early diagnosis, especially in the case
of PVE, for which echocardiography is normal or incon-
clusive in almost 30% of cases (6,7).
Recently, 18F-ﬂuorodeoxyglucose positron emission tomog-
raphy/computed tomography (18F-FDG PET/CT) has been
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2375employed to identify inﬂammatory and infectious processes
(8). Thus, several studies have demonstrated the role of PET/
CT in detecting vascular prosthesis (9–11) and implantable
pacemaker/deﬁbrillator infections (12–14). Moreover, some
case reports have suggested a possible role for this technique in
diagnosing PVE (15–18), but no study has addressed this
issue to date.
Therefore, we aimed to assess the diagnostic value of PET/
CT in PVE and to determine whether the addition of
abnormal FDG uptake as a major diagnostic criterion would
improve the early sensitivity of the Duke classiﬁcation upon
the admission of patients with suspected PVE.SUVmax = maximal
standardized uptake value
TEE = transesophageal
echocardiography
TTE = transthoracic
echocardiographyMethods
Patients. From January 2011 to June 2012, all consecutive
adults admitted to the Department of Cardiology at
Timone Hospital (Marseille, France) with a suspected
diagnosis of PVE were prospectively eligible for entry to the
study. In patients with a prosthetic valve, endocarditis was
suspected in the presence of at least 1 of the following
criteria: 1) unexplained persistent or recurrent fever >38C;
2) unexplained increase in serum C-reactive protein (CRP)
level >10 mg/l; 3) positive blood cultures, independent of
the echocardiographic analysis results; 4) positive serological
testing for Coxiella burnetii, Bartonella spp., Mycoplasma
pneumoniae, Legionella pneumophila, Aspergillus spp., or
Tropheryma whipplei; and 5) a mass or a new partial pros-
thetic valve dehiscence observed using echocardiography.
The patient exclusion criteria were pregnancy, inability to lie
ﬂat, need for urgent cardiac surgery, hemodynamic insta-
bility, cardiac surgery <1 month ago, and blood glucose level
>1.8 g/l. All of the patients had clinical, microbiological,
and echocardiographic evaluations and PET/CT. Patients
with poor PET/CT image quality were also excluded.
Written informed consent was obtained from all of the
participating patients using an approved protocol, which was
required by the institutional review board.
Clinical,microbiological, and echocardiographic data. The
following data were collected from the patients at admission
and during hospitalization: age, sex, and Charlson comor-
bidity index (19); history of diabetes, cancer, intravenous drug
use, underlying heart disease, chronic renal insufﬁciency,
and heart failure; leukocyte count, serum CRP level, and
causative pathogens (determined by blood culture, serology
testing, valve culture, or polymerase chain reaction from
a valve specimen according to international guidelines [20]);
and indications for valve surgery. Transthoracic echocardio-
graphic (TTE) and transesophageal echocardiographic
(TEE) analyses were performed in all patients at admission,
and the data were interpreted by experienced senior cardiol-
ogists as previously described (21). TTE and TEE were
repeated weekly during the hospitalization period. Brieﬂy,
the echocardiographic data included the presence and maxi-
mal length of vegetations. Periannular complications were
deﬁned as an abscess, pseudoaneurysm, or ﬁstula according toaccepted deﬁnitions (2). The data
were stored electronically and
noted the time of the original
examination without alteration.
Valvular regurgitation was semi-
quantitatively assessed (22). The
left ventricular ejection fraction
was quantiﬁed using the Simpson
biplane method.
18F-ﬂuorodeoxyglucose PET/
CT. After eating a meal rich in
fat and very low in carbohydrates
to reduce the physiological uptake
of FDG in the myocardium, the
patients fasted for at least 12 h
prior to PET/CT. Intravenous
administration of 5 MBq/kg 18F-
FDG was performed after the
blood glucose level (<1.8 g/l) was
checked. PET and whole-body CT scans were carried out
consecutively using a Discovery ST PET/CT scanner
(General Electric,Milwaukee,Wisconsin) 1 h after 18F-FDG
injection. The PET data were acquired in 3-dimensional
mode, and the images were corrected for attenuation and
reconstructed using the OSEM (ordered-subset-expectation-
maximization) algorithm. The PET data were linked with
the CT data. The data analysis (Xeleris, General Electric)
was based on visual interpretation and quantitative measure-
ment of FDG uptake using the following criteria:
Visual analysis: hypermetabolic intensities in the pros-
thetic and periprosthetic areas were considered to be
abnormal. This uptake had to be conﬁrmed in the
uncorrected images. This visual analysis deﬁned whether
the PET/CT was positive or negative.
Semiquantitative analysis: the intensity of FDG uptake was
determined by measuring the maximal standardized uptake
value (SUVmax), which was obtained by normalizing
the tissue concentration of FDG activity and the patient’s
weight. SUVmax was calculated using an average of 3
measurements from3volumes of interest (5mm3) introduced
in the prosthetic region at equal distances from each other.
To obtain a background value for FDG uptake, blood SUV
was determined by introducing 35-mm3 volumes of interest
within the right atrium in locations devoid of signiﬁcant
spillover activity. The prosthetic valve-to-background
ratio was calculated by dividing the prosthetic valve SUVmax
by the atrial blood SUVmax. This ratio allowed possible biases
related todifferences in theFDGmetabolism tobeovercome.
In addition, whole-body acquisition was performed to
detect silent embolic events and septic metastases deﬁned
as extracardiac abnormal uptakes. Some abnormal uptakes
could also correspond to the incidental discovery of
tumors. The calculated mean radiation dose for a whole-
body 18F-FDG PET/CT was 15 mSv.
The images were interpreted by 2 nuclear medicine physi-
cians who were blinded to the clinical data and the applied
Table 1
Deﬁnition of Prosthetic Valve Endocarditis
According to the Proposed Modiﬁed PET/CT
Duke Criteria
Deﬁnite infective endocarditis
Pathological criteria
1. Microorganisms demonstrated by culture or histological examination
of a vegetation, a vegetation that has embolized, or an intracardiac abscess specimen
or
2. Pathological lesions; vegetation or intracardiac abscess conﬁrmed
by histological examination showing active endocarditis
Clinical criteria
1. 2 major criteria or
2. 1 major criterion and 3 minor criteria or
3. 5 minor criteria
Possible infective endocarditis
1. 1 major criterion and 1 minor criterion or
2. 3 minor criteria
Rejected infective endocarditis
1. Firm alternate diagnosis explaining evidence of infective endocarditis or
2. Resolution of infective endocarditis syndrome with antibiotic therapy
for 4 days or
3. No pathological evidence of infective endocarditis at surgery or autopsy, with
antibiotic therapy for 4 days or
4. Does not meet criteria for possible infective endocarditis, as above
Major criteria
Blood culture positive for infective endocarditis
Typical microorganisms consistent with infective endocarditis from 2 separate blood
cultures
Viridans streptococci, Streptococcus bovis, HACEK group, Staphylococcus
aureus or
Community-acquired enterococci, in the absence of a primary focus or
Microorganisms consistent with infective endocarditis from persistently positive blood
cultures, deﬁned as follows
2 positive cultures of blood samples drawn >12 h apart or
all of 3 or a majority of 4 separate cultures of blood (with ﬁrst and last sample
drawn at least 1 h apart)
Single positive blood culture for Coxiella burnetii or antiphase I IgG antibody
titer >1:800
Evidence of endocardial involvement
Echocardiogram (TTE and/or TEE) positive for infective endocarditis deﬁned as
follows
Oscillating intracardiac mass on valve or supporting structures, in the path of
regurgitant jets, or on implanted material in the absence of an alternative
anatomic explanation or
Abscess or
New partial dehiscence of prosthetic valve
New valvular regurgitation (worsening or changing of pre-existing murmur not
sufﬁcient)
Positive 18F-FDG PET/CT: abnormal FDG uptake at the site of prosthetic valve
Minor criteria
Predisposition, predisposing heart condition, or injection drug use
Fever, temperature >38C
Vascular phenomena: major arterial emboli, septic pulmonary infarcts,
mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages,
Janeway lesions
Immunological phenomena: glomerulonephritis, Osler nodes, Roth spots,
rheumatoid factor
Microbiological evidence: positive blood culture but does not meet a major criterion as
noted above or serological evidence of active infection with organism consistent with
infective endocarditis
In the underlined text, the novel major criterion has been added to the previous modiﬁed Duke
classiﬁcation.
FDG ¼ ﬂuorodeoxyglucose; HACEK ¼ Haemophilus species, Actinobacillus actino-
mycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella species; IgG ¼
immunoglobulin G; PET/CT ¼ positron emission tomography/computed tomography; TEE ¼
transesophageal echocardiography; TTE ¼ transthoracic echocardiography.
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2376imaging convention. In the cases of disagreement, a consensus
was reached via a third physician. Patient management was
performed independently of the PET/CT results.
Gold standard. The ﬁnal diagnosis was deﬁned by an
expert team according to the clinical and/or pathological
modiﬁed Duke criteria determined from the data collected
during a 3-month follow-up after admission (4). Follow-up
after hospital discharge was actively conducted based on
consultations at 1 and 3 months, TTE and/or TEE, blood
cultures, and biological samples in our department or by
contacting the patients or their physicians.
Statistical analysis. Continuous variables were expressed as
the median (interquartile range [IQR]) and compared using
the Mann-Whitney U test. Categorical data were expressed
as numbers (percentages) and compared using the chi-square
or Fisher exact test.
In the ﬁrst analysis, we determined the diagnostic value
of PET/CT (presence or absence of abnormal FDG uptake
at the prosthetic valve site). The sensitivity, speciﬁcity,
positive predictive value, negative predictive value, and
accuracy, as well as the 95% conﬁdence interval (CI), were
calculated using the ﬁnal diagnoses of deﬁnite PVE and
rejected PVE as the outcomes. The prosthetic SUVmax and
SUVmax/right atrium ratio were compared among the deﬁ-
nite, possible, and rejected ﬁnal diagnoses using the Kruskal-
Wallis test and post hoc Dunn test.
In the second analysis, we added abnormal FDG uptake
at the prosthetic valve as an additional major criterion in the
modiﬁed Duke classiﬁcation. Then we compared the early
diagnostic value at admission of this novel Duke classiﬁca-
tion (Duke-PET/CT) with the classic Duke classiﬁcation
(Duke) (Table 1). The sensitivities and speciﬁcities were
compared using the McNemar test. The net reclassiﬁcation
index was calculated to assess the improvement in the
diagnosis categorization (23).
The analysis was performed according to the Standards
for Reporting of Diagnostic Accuracy guidelines (24). Three
patients of the present population were previously described
in a recent case report publication (15).
The interobserver variability of PET-CT was assessed
using the kappa test.
The analyses were performed using SPSS version 16.0
(SPSS Inc., Chicago, Illinois). All of the tests were 2 sided.
A p value <0.05 was considered to be signiﬁcant.
Results
Baseline characteristics. Seventy-two patients with sus-
pected PVE were included during the study period (Fig. 1).
The median age of the patients was 67 years (IQR: 60 to
76 years), and 61% were male. The baseline characteristics
are summarized in Table 2. At the end of follow-up, the
ﬁnal diagnosis was classiﬁed as deﬁnite PVE in 30 patients,
rejected PVE in 20, and possible PVE in 22. Fifty-nine
patients received antibiotic treatment during hospitaliza-
tion. Of the 29 patients who underwent cardiac surgery,
Figure 1 Study Flow Chart
Of the 91 patients with suspicion of prosthetic valve endocarditis (PVE), 72 were
included and classiﬁed according to the ﬁnal diagnosis determined using the
modiﬁed Duke criteria established after a 3-month follow-up. PET/CT ¼ positron
emission tomography/computed tomography.
Table 2
Baseline Characteristics of the 76 Patients With
PVE Suspicion
Age, yrs 67 (60–76)
Male 44 (61)
Diabetes 17 (24)
History of cancer 9 (13)
Comorbidity index 4 (2–6)
Type of prosthesis
Bioprosthetic valve 44 (61)
Mechanical valve 28 (39)
Biology
CRP, mg/l 22 (7–98)
White cells, 109/l 8 (6–11)
Causative pathogen
Positive blood cultures 24 (33)
Staphylococcus aureus 16 (22)
Enterococcus faecalis 7 (10)
Streptococcus bovis 4 (6)
Other streptococci 2 (3)
Coagulase-negative staphylococci 3 (4)
Others 10 (14)
Echocardiography
Vegetation 27 (38)
Periannular complications 8 (11)
New partial dehiscence 13 (18)
LVEF <45% 7 (10)
Cardiac surgery 29 (40)
Values are median (interquartile range) or n (%).
CRP ¼ C-reactive protein; LVEF ¼ left ventricular ejection fraction; PVE ¼ prosthetic value
endocarditis; other abbreviation as in Table 1.
Table 3 Results of PET/CT According to the Final Diagnosis
Final Diagnosis
Deﬁnite PVE Possible PVE Rejected PVE
Positive PET/CT 22 (73) 10 (45) 4 (20)
Negative PET/CT 8 (27) 12 (55) 16 (80)
Values are n (% of each ﬁnal diagnosis).
Abbreviations as in Tables 1 and 2.
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2377PVE was pathologically proven in 13 individuals. The
indications for surgery were heart failure (n ¼ 16), peri-
annular abscess (n ¼ 12), and high embolic risk (n ¼ 8).
Surgery consisted of implantation of bioprosthesis (n ¼ 22),
homograft (n ¼ 5), and mechanical prosthesis (n ¼ 2).
Diagnostic value of cardiac PET/CT. PET/CT was
performed at a median time of 6 days (IQR: 4 to 11 days)
after admission, 30 days (IQR: 6 to 46 days) after onset of
symptoms, and 1,484 days (IQR: 526 to 3,396 days) after
implantation of the prosthetic valve. In the 55 patients who
received antibiotic therapy, PET/CT was performed at
a median time of 9 days (IQR: 5 to 19 days) after the
beginning of this treatment. A total of 36 of the patients
(50%) showed abnormal FDG uptake at the prosthetic valve
(positive PET/CT). There was no difference in the rate of
positive PET/CT between patients with biological and
mechanical prosthetic valves (52% vs. 46%; p ¼ 0.63). The
interobserver reproducibility was 86% (kappa ¼ 0.71).
The results of PET/CT according to the ﬁnal diagnosis
are summarized in Table 3. The sensitivity, speciﬁcity,
positive predictive value, negative predictive value, and
global accuracy were 73% (95% CI: 54% to 87%), 80% (95%
CI: 56% to 93%), 85% (95% CI: 64% to 95%), 67% (95%
CI: 45% to 84%), and 76% (95% CI: 63% to 86%),
respectively. Among the 13 patients with pathologically
proven PVE, the PET/CT results were positive in 12
patients (92%), whereas echocardiography on admission was
positive in only 7 patients (54%). Among the 7 patients who
underwent surgery with a negative PET/CT, none had
a pathologically proven PVE.
PET/CT was positive in 4 patients with a rejected PVE
diagnosis (false positive 15%). Two of these individuals
showed abnormal FDG uptake in an ascending aortic graft
implanted with a prosthetic valve. In these 2 cases, it wasdifﬁcult to determine whether the abnormal FDG uptake
involved the prosthetic valve or only the aortic root. Addi-
tionally, 1 patient exhibited mechanical prosthesis throm-
bosis with negative tissue culture results after surgery and 1
presented an acute mitral chordae rupture associated with
low FDG uptake in the aortic bioprosthetic valve, which
appeared normal based on echocardiography. Eight patients
with deﬁnite PVE showed normal cardiac PET/CT results
(false negative 33%). PET/CT was conducted in these
patients at a median time of 8.5 days (IQR: 4 to 13 days) after
starting antibiotics; in the patients with deﬁnite PVE and
positive PET/CT, this analysis was performed after a median
time of 7 days (IQR: 5 to 16 days) (p ¼ 0.85). The serum
CRP level was higher in patients with positive PET/CT, but
the difference was not statistically signiﬁcant (56 mg/l [IQR:
10 to 116 mg/l] vs. 64 mg/l [IQR: 12 to 158 mg/l];
p ¼ 0.43]). Figure 2 shows examples of PET/CT results.
Figure 2 Examples of True- and False-Positive PET/CT Results
(A and B) PET/CT results in a patient with a deﬁnite diagnosis of PVE 22 days after a transcatheter aortic valve implantation (Corevalve). The high ﬂuorodeoxyglucose (FDG)
uptake (yellow arrows) is observed at the level of the anterior aortic annulus, where an abscess was conﬁrmed by echocardiography and during surgery. The maximal
standardized uptake value (SUVmax) was 7 g/ml. (C and D) PET/CT results in a patient with a rejected diagnosis of PVE but an abnormal uptake of FDG (yellow arrows) at the
level of an aortic root graft and next to a mechanical aortic prosthetic valve (Bentall procedure). This false-positive result might be explained by an inﬂammatory response
to the BioGlue surgical adhesive (a topically applied mixture of bovine serum albumin and glutaraldehyde) used to seal the aortic root graft. The SUVmax was 2.9 g/ml.
Abbreviations as in Figure 1.
Saby et al. JACC Vol. 61, No. 23, 2013
PET/CT in Prosthetic Valve Endocarditis June 11, 2013:2374–82
2378Among the 30 patients with deﬁnite PVE, 15 patients
(50%) exhibited both a positive initial echocardiogram at
admission and positive PET/CT, 7 patients (23%) presented
a positive PET/CT despite a negative initial echocardiogram,
and 8 patients (27%) exhibited a negative PET/CT despite
a positive initial echocardiogram. Thus, no patient with
deﬁnite PVE displayed both a negative initial echocardiogram
and negative PET/CT. Of the 12 patients with a positive
PET/CT and negative initial echocardiography, 7 had
a deﬁnite PVE, and a periprosthetic abscess was identiﬁed in6 individuals during repeated echocardiographic study
(Fig. 3) performed at a median time of 8 days (IQR: 7 to 23
days).
The PET/CT was positive in 11 of the 20 patients (55%)
with only a vegetation shown in the initial echocardiogram,
5 of the 8 patients (63%) presented periannular complica-
tions, and 7 of the 13 patients (54%) exhibited new partial
dehiscence of the prosthetic valve (Table 4).
The semiquantitative analysis of FDG uptake showed
a signiﬁcant higher prosthetic valve SUVmax in patients with
Figure 3 Example of Positive PET/CT in a Patient With PVE and Normal Initial Echocardiography
The ﬁrst transesophageal echocardiogram did not show any abnormalities around the aortic bioprosthetic annulus (B). The second transesophageal echocardiogram, performed
at the end of antibiotic treatment (1 month later), showed a large periprosthetic abscess (C, red arrow). The 18F-FDG PET/CT performed 3 days after the ﬁrst echocardiogram
showed an abnormal uptake around the aortic prosthesis (A, yellow arrow) and another hyperintensity in the left colon, revealing a cancer (A, green arrow) that was conﬁrmed
by colonoscopy. The PET/CT images are presented as fused (PETþCT) and attenuation-corrected maximal intensity (MIP) projection images. Abbreviations as in Figures 1 and 2.
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2379deﬁnite PVE in comparison with the other groups and trend
toward a higher prosthetic valve-to-background SUVmax
ratio (Fig. 4).
Cardiac PET/CT as a major Duke criterion. The addi-
tion of abnormal FDG uptake at the site of the prosthetic
valve as a novel major criterion signiﬁcantly increased the
sensitivity of the modiﬁed Duke criteria established atTable 4
Results of PET/CT According to the Results of the
Initial Echocardiography Study (TTE and TEE)
Positive PET/CT Negative PET/CT p Value
Vegetation 16 (59) 11 (41) 0.22
Periannular complications 5 (63) 3 (37) 0.71
New partial dehiscence 7 (54) 6 (46) 0.76
Values are n (% of each echocardiographic result).
Abbreviations as in Table 1.admission (70% [95% CI: 52% to 83%] vs. 97% [95% CI:
83% to 99%]; p ¼ 0.008). This result was the consequence
of a signiﬁcant reduction (p < 0.0001) in the number of
possible PVE cases from 40 (56%) to 23 (32%). With this
strategy, the speciﬁcity was not signiﬁcantly decreased (50%
[95% CI: 30% to 70%] vs. 40% [95% CI: 22% to 61%]; p ¼
0.5) (Table 5). The net reclassiﬁcation index was 10.3%.
The results of the Duke and Duke-PET/CT criteria are
summarized for all of the patients in the Online Appendix,
Online Table 1.
Whole-body PET/CT to detect emboli, distant infection,
and portal of entry. Whole-body PET/CT identiﬁed
emboli and distant infection in 8 patients (3 splenic emboli
and 5 spondylodiscitis). Only one of these lesions was silent.
Thus, the results of applying this technique did not signif-
icantly improve the value of the modiﬁed Duke criteria. In
Figure 4 Results of the Prosthetic Valve SUVmax and Prosthetic Valve-to-Background SUVmax Ratio According to the Final Diagnosis
The SUVmax was signiﬁcantly higher in patients with deﬁnite PVE in comparison with the 2 other groups (A), whereas the prosthetic valve-to-background SUVmax ratio was not
signiﬁcantly higher (B). *p < 0.05. Abbreviations as in Figures 1 and 2.
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2380addition, 8 patients had a colonic abnormal FDG uptake.
Among them, colonoscopy with biopsies identiﬁed cancer in
2 patients and low-grade dysplasia in 3 patients.
Discussion
PVE represents a diagnostic challenge. The present study
tested the use of 18F-FDG PET/CT for diagnosing PVE.
We demonstrated that this imaging technique has good
diagnostic value, especially when abnormal FDG uptake
around the prosthetic valve was added as a major criterion to
the modiﬁed Duke classiﬁcation established within a few
days after admission. The inclusion of this new criterion
signiﬁcantly increased the sensitivity of the modiﬁed Duke
classiﬁcation and allowed for an earlier diagnosis, especially
when echocardiography was normal or doubtful.
The early diagnosis of endocarditis is of crucial importance
because a delay in antibiotic therapy and cardiac surgery has
negative effects on clinical outcomes (3,25). However, diag-
nosis of this condition is often difﬁcult, especially in theTable 5
Diagnostic Value of the Modiﬁed Duke Criteria at
Admission With (Duke-PET/CT) and Without the
Implementation of the PET/CT Results
Final Diagnosis
Deﬁnite PVE Possible PVE Rejected PVE
Duke
Deﬁnite PVE 21 (70) 0 (0) 0 (0)
Possible PVE 8 (27) 22 (100) 10 (50)
Rejected PVE 1 (3) 0 (0) 10 (50)
Duke-PET/CT
Deﬁnite PVE 29 (97) 10 (45) 2 (10)
Possible PVE 1 (3) 12 (55) 10 (50)
Rejected PVE 0 0 8 (40)
Values are n (% of each ﬁnal diagnosis).
Abbreviations as in Tables 1 and 2.presence of foreign materials such as pacemaker/deﬁbrillator
leads and prosthetic valves. In such a situation, echocardi-
ography shows a decreased sensitivity and speciﬁcity (2,26).
Therefore, efforts have been made to develop new imaging
strategies to accelerate the diagnostic process. Although
the interest in cardiac CT for use in some situations has
increased (27), similar to echocardiography, cardiac CT is still
a morphological imaging modality that lacks functional data,
which is a major limitation when microbiological data are
negative and in the case of absent or doubtful structural
lesions. Labeled leukocyte scintigraphy is another option for
imaging, but this technique is time consuming (28). By
measuring metabolic tissue activity, 18F-FDG PET/CT has
emerged as a promisingmethod for diagnosing cardiovascular
infections (29). In a large contemporary cohort of patients
with presumed PVE, we found that the sensitivity and
speciﬁcity of this technique were 73% and 80%, respectively.
These results were similar to data from Bensimhon et al. (12)
on pacemaker lead endocarditis. Although these results are
good, we cannot conclude that PET/CT alone is the “magic”
modality capable of diagnosing any PVE episodes. Indeed,
such an imaging test is difﬁcult to imagine for a complex
disease such as endocarditis. However, when the results
of PET/CT were taken into account together with other
clinical, microbiological, and echocardiographic parameters,
our ﬁndings showed that the sensitivity of the modiﬁed
Duke criteria dramatically increased to 97%, a rate never
reported previously for this disease. This result was obtained
without compromising speciﬁcity. Moreover, the inclusion
of cardiac PET/CT in the diagnostic strategy demonstrated
the potential of the modiﬁed Duke criteria to provide a
diagnosis earlier in the course of the disease because the
criteria were initially developed to deﬁne cases of endocarditis
for epidemiological studies conducted at the end of patient
follow-up (4).
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2381As previously suggested, the major contribution of PET/
CT to the early diagnosis of PVE appears to be related to
cases for which the initial echocardiographic analysis is
negative (15). In addition, abnormal FDG uptake was
observed before the appearance of infectious damage in
echocardiography in several patients, which highlights the
power of PET/CT to reveal infection before signiﬁcant
damage has occurred. Our medical team has recently
proposed the inclusion of PET/CT in the strategy of the
difﬁcult diagnosis of Q fever endocarditis, for which echo-
cardiography usually shows atypical lesions (30).
The improvement in the sensitivity of the modiﬁed Duke
criteria obtained by including the PET/CT data resulted
from a signiﬁcant decrease in the rate of possible PVE
diagnoses. The possible PVE group has represented
a problem in therapeutic decision making because of the
potential delay in initiating antibiotic treatment, which can
lead to severe complications, such as embolism, cerebral
hemorrhage, and acute heart failure. By reclassifying the
majority of possible PVE cases to deﬁnite PVE, PET/CT
might have an impact on therapeutic strategies and clinical
outcomes in the future.
Study limitations. Although the results of the PET/CT
analysis are encouraging, we did observe false-positive and
false-negative tests. The few deﬁnite PVE cases with negative
PET/CT might be explained by the patients presentingFigure 5 Proposed Algorithm for Evaluating Patients With Suspected
This algorithm integrates the results of the present study by implementation of PET/CT in
after the initial evaluation using the modiﬁed Duke criteria. Thus, in case of possible PVE
performed by using the PET/CT 2013-modiﬁed Duke criteria. These new criteria will allow
as in Figure 1.disease with a lower inﬂammatory activity or PET/CT that
was performed too long after initiating antibiotic therapy.
The optimal timing for performing PET/CT, according to
the onset of antibiotic treatment, should be determined in
future studies. In addition, false-positive results of PET/CT
may occur when this technique is performed too early after
the implantation of the prosthetic valve (31). In the present
study, the patients with cardiac surgery performed <1 month
earlier were not included to avoid these false-positive results
related to the early post-operative inﬂammation around
the sewing ring. We identiﬁed other possible causes of
false positives, such as severe prosthetic thrombosis or the
presence of an aortic root graft. In the latter case, abnormal
FDG could be related to the BioGlue surgical adhesive
(a topically applied mixture of bovine serum albumin and
glutaraldehyde) used to seal the aortic root graft, as reported
by Schouten et al. (32). The limited spatial resolution of the
PET/CT used in this study did not allow us to determine
whether the FDG uptake was present only on the aortic root
graft or also involved the prosthetic valve.
The ﬁnal diagnosis determined according to the results of
modiﬁedDuke criteria at the end of the follow-up was used as
the gold standard in this study. Although this choice could be
criticized, this decision allowed the inclusion of patients in
whom surgical specimens could not be systematically obtained
because of a nonsurgical therapeutic strategy. Furthermore,PVE Using PET/CT
the diagnostic strategy of patients in whom the diagnosis of PVE remains uncertain
, or rejected PVE associated with high clinical suspicion, a new evaluation should be
the detection of more deﬁnite diagnoses thanks to a higher sensitivity. Abbreviations
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2382the favorable results regarding PET/CT sensitivity were
conﬁrmed when a surgical specimen positive for infection was
used as the gold standard.
Conclusions
The 18F-FDG PET/CT imaging technique was useful for
diagnosing PVE. This imaging modality is not a substitute
for clinical, microbiological, and echocardiographic evalua-
tion but could be implemented in the global assessment of
patients with suspected PVE. By demonstrating the
potential role of this methodology in early diagnosis, espe-
cially in the case of initial negative echocardiography results,
we showed the signiﬁcant diagnostic impact when positive
PET/CT was used as a novel major Duke criterion.
Moreover, whole-body imaging was also useful for detecting
emboli, metastatic infection, and occult primary tumors.
Based on these results, we have proposed an algorithm for
incorporating PET/CT in the evaluation of patients with
suspected PVE (Fig. 5). Future large-scale studies will be
necessary to conﬁrm whether this strategy is cost effective.
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